Vaxart, Inc. Tax Withholding Paid on Stock Awards
Vaxart, Inc. (VXRT) reported Tax Withholding Paid on Stock Awards of $364.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- Vaxart, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $26.00K, a 271.43% increase year-over-year.
- Vaxart, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $338.00K, a 102.40% increase year-over-year.
- Vaxart, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $21.00K, a 250.00% increase year-over-year.
- Vaxart, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $4.00K, a 55.56% decline year-over-year.
- Vaxart, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $366.00K.
- Vaxart, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.00K derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | $364.00K 10-Q · filed 2026-08-06 | $385.00K derived: sum of 3 quarters · filed 2026-08-06 | $389.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $338.00K S-1 · filed 2026-05-08 | $359.00K derived: sum of 2 quarters · filed 2026-05-08 | $363.00K derived: sum of 3 quarters · filed 2026-05-08 | $370.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $21.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $25.00K derived: sum of 2 quarters · filed 2026-05-08 | $32.00K derived: sum of 3 quarters · filed 2026-08-06 | $199.00K S-1 · filed 2026-05-08 |
| 2025-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $11.00K derived: sum of 2 quarters · filed 2026-08-06 | $178.00K 10-Q · filed 2025-11-13 | $184.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.00K derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | $174.00K 10-Q · filed 2026-08-06 | $180.00K derived: sum of 3 quarters · filed 2026-08-06 | $189.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $167.00K S-1 · filed 2026-05-08 | $173.00K derived: sum of 2 quarters · filed 2026-05-08 | $182.00K derived: sum of 3 quarters · filed 2026-05-08 | $199.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $6.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $15.00K derived: sum of 2 quarters · filed 2026-05-08 | $32.00K derived: sum of 3 quarters · filed 2026-05-08 | $214.00K S-1 · filed 2026-05-08 |
| 2024-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $26.00K derived: sum of 2 quarters · filed 2025-11-13 | $208.00K 10-Q · filed 2025-11-13 | $535.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $199.00K 10-Q · filed 2025-08-13 | $526.00K derived: sum of 3 quarters · filed 2025-08-13 | $534.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $182.00K 10-Q · filed 2025-05-13 | $509.00K derived: sum of 2 quarters · filed 2025-05-13 | $517.00K derived: sum of 3 quarters · filed 2025-05-13 | $538.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $335.00K derived: sum of 2 quarters · filed 2025-03-20 | $356.00K derived: sum of 3 quarters · filed 2025-03-20 | $366.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $29.00K derived: sum of 2 quarters · filed 2024-11-13 | $39.00K 10-Q · filed 2024-11-13 | $39.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $31.00K 10-Q · filed 2024-08-08 | $31.00K derived: sum of 3 quarters · filed 2024-08-08 | $31.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-13 | $10.00K derived: sum of 2 quarters · filed 2024-05-13 | $10.00K derived: sum of 3 quarters · filed 2024-05-13 | $10.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $0.00 10-K · filed 2024-03-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |